SUBSCRIBE
SUBSCRIBE
News   Deals

Ipsen Aims To Raise €400 Million In IPO

November 23, 2005 | 
1 min read
Ipsen, the French pharmaceuticals company, yesterday unveiled plans to raise about €400m ($470m) in an initial public offering, which would reduce the stake of the family of founder Henri Beaufour and raise funds for research.
IPO Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
Businessman on a crossroad. Man choosing career. Searching of right path. Decision and brainstorming concept. Flat vector illustration.
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
 · 
2 min read
 · 
Annalee Armstrong
People balance on tightly stretched ropes. Art collage.
Deals
M&A, IPOs Snarled by Policy Reality in Q1 as Pharmas Opt for Licensing Deals
May 7, 2025
 · 
3 min read
 · 
Annalee Armstrong
Brain shaped maze. Conceptual image of science and medicine. 3D illustration.
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong